ArticleFrontiers in oncology2020

DNA-PK Inhibitor, M3814, as a New Combination Partner of Mylotarg in the Treatment of Acute Myeloid Leukemia.

Michael I Carr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.